​
​

Verrica Pharmaceuticals (VRCA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Verrica Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$5.12M

Latest Revenue (Q)

$-1.86M

Main Segment (Y)

Product

Verrica Pharmaceuticals Revenue by Period

Verrica Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31$5.12M-43.27%
2022-12-31$9.03M-24.73%
2021-12-31$12.00M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--

Verrica Pharmaceuticals generated $5.12M in revenue during NA 2023, up -43.27% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Verrica Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30$-1.86M-136.02%
2024-06-30$5.18M35.31%
2024-03-31$3.83M92.45%
2023-12-31$1.99M-31.85%
2023-09-30$2.92M1502.75%
2023-06-30$182.00K391.89%
2023-03-31$37.00K-45.59%
2022-12-31$68.00K-99.18%
2022-09-30$8.32M3787.38%
2022-06-30$214.00K-50.35%
2022-03-31$431.00K-103.59%
2021-12-31$-12.00M100.00%
2021-09-30-100.00%
2021-06-30--100.00%
2021-03-31$12.00M100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

Verrica Pharmaceuticals generated $-1.86M in revenue during Q3 2024, up -136.02% compared to the previous quarter, and up -1024.73% compared to the same period a year ago.

Verrica Pharmaceuticals Revenue Breakdown

Verrica Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23
Collaboration$466.00K
Product$4.66M

Verrica Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (90.91%), and Collaboration (9.09%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24
Collaboration$84.00K$285.00K$594.00K
Product$-1.86M$4.89M$3.23M

Verrica Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Collaboration (-4.72%), and Product (104.72%).

Verrica Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ASNDAscendis Pharma$266.72M$95.89M
ARQTArcutis Biotherapeutics$59.61M$30.86M
ETONEton Pharmaceuticals$31.64M$10.32M
FENCFennec Pharmaceuticals$21.64M$6.97M
IVAInventiva$17.50M$15.58M
KDNYChinook Therapeutics$6.13M$1.01M
VRCAVerrica Pharmaceuticals$5.12M$-1.86M
CRNXCrinetics Pharmaceuticals$4.01M-
PLRXPliant Therapeutics$1.58M-
FIXXQ32 Bio$1.16M-
LIANLianBio--
CNTBConnect Biopharma--
DICEDICE Therapeutics--
ABOSAcumen Pharmaceuticals--
VRNAVerona Pharma-$5.62M
LRMRLarimar Therapeutics--
VIGLVigil Neuroscience--
EWTXEdgewise Therapeutics--
NUVBNuvation Bio-$727.00K
ELDNEledon Pharmaceuticals--

VRCA Revenue FAQ

What is Verrica Pharmaceuticals’s yearly revenue?

Verrica Pharmaceuticals's yearly revenue for 2023 was $5.12M, representing a decrease of -43.27% compared to 2022. The company's yearly revenue for 2022 was $9.03M, representing a decrease of -24.73% compared to 2021. VRCA's yearly revenue for 2021 was $12M, representing an increase of 100.00% compared to 2020.

What is Verrica Pharmaceuticals’s quarterly revenue?

Verrica Pharmaceuticals's quarterly revenue for Q3 2024 was $-1.865M, a -136.02% decrease from the previous quarter (Q2 2024), and a -163.94% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $5.18M, a 35.31% increase from the previous quarter (Q1 2024), and a 2744.51% increase year-over-year (Q2 2023). VRCA's quarterly revenue for Q1 2024 was $3.83M, a 92.45% increase from the previous quarter (Q4 2023), and a 10240.54% increase year-over-year (Q1 2023).

What is Verrica Pharmaceuticals’s revenue growth rate?

Verrica Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was -57.30%, and for the last 5 years (2019-2023) was 0%.

What are Verrica Pharmaceuticals’s revenue streams?

Verrica Pharmaceuticals's revenue streams in c 23 are Collaboration, and Product. Collaboration generated $466K in revenue, accounting 9.09% of the company's total revenue Product generated $4.66M in revenue, accounting 90.91% of the company's total revenue

What is Verrica Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Verrica Pharmaceuticals was Product. This segment made a revenue of $4.66M, representing 90.91% of the company's total revenue.